MRIN vs. BIAF, CHR, MULN, PMEC, HLGN, NXTT, MOBQ, FTFT, AWX, and SYRA
Should you be buying Marin Software stock or one of its competitors? The main competitors of Marin Software include bioAffinity Technologies (BIAF), Cheer (CHR), Mullen Automotive (MULN), Primech (PMEC), Heliogen (HLGN), Next Technology (NXTT), Mobiquity Technologies (MOBQ), Future FinTech Group (FTFT), Avalon (AWX), and Syra Health (SYRA). These companies are all part of the "business services" industry.
bioAffinity Technologies (NASDAQ:BIAF) and Marin Software (NASDAQ:MRIN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, community ranking, risk, earnings, profitability, media sentiment and valuation.
1.6% of bioAffinity Technologies shares are held by institutional investors. Comparatively, 9.5% of Marin Software shares are held by institutional investors. 36.4% of bioAffinity Technologies shares are held by insiders. Comparatively, 9.3% of Marin Software shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
bioAffinity Technologies has a beta of 2.99, indicating that its share price is 199% more volatile than the S&P 500. Comparatively, Marin Software has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500.
bioAffinity Technologies and Marin Software both received 1 outperform votes by MarketBeat users. However, 100.00% of users gave bioAffinity Technologies an outperform vote while only 2.08% of users gave Marin Software an outperform vote.
In the previous week, bioAffinity Technologies had 2 more articles in the media than Marin Software. MarketBeat recorded 5 mentions for bioAffinity Technologies and 3 mentions for Marin Software. bioAffinity Technologies' average media sentiment score of 0.38 beat Marin Software's score of 0.37 indicating that Marin Software is being referred to more favorably in the news media.
Marin Software has a net margin of -107.95% compared to Marin Software's net margin of -171.43%. bioAffinity Technologies' return on equity of -78.95% beat Marin Software's return on equity.
bioAffinity Technologies presently has a consensus price target of $6.00, indicating a potential upside of 121.40%. Given Marin Software's higher possible upside, research analysts clearly believe bioAffinity Technologies is more favorable than Marin Software.
bioAffinity Technologies has higher earnings, but lower revenue than Marin Software. bioAffinity Technologies is trading at a lower price-to-earnings ratio than Marin Software, indicating that it is currently the more affordable of the two stocks.
Summary
bioAffinity Technologies beats Marin Software on 9 of the 16 factors compared between the two stocks.
Get Marin Software News Delivered to You Automatically
Sign up to receive the latest news and ratings for MRIN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MRIN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Marin Software Competitors List
Related Companies and Tools
